Melatonin preparations such as Sleepose are classified as prescription-only medicines (POM) in the United Kingdom. A qualified prescriber must authorize their use.
Most individuals notice a sleep-promoting effect within 30-60 minutes after taking the 10 mg pill, with peak activity occurring around 1-2 hours post-dose.
Sleepose is approved for short-term use (up to three weeks) in adults ≥ 55 years. Long-term nightly use should only be considered under close medical supervision.
Vivid or unusual dreams are a known, generally harmless side effect. If they become disturbing, discuss dose timing or reduction with your prescriber.
Both melatonin and antihistamines can cause sedation. Combining them may increase drowsiness; consult a healthcare professional before co-administration.
Alcohol can intensify melatonin’s sedative effect and may impair sleep quality. It is advisable to limit alcohol intake when using Sleepose.
Melatonin is metabolised by the liver, but routine dosing does not typically alter standard liver function tests. Specific monitoring is only needed for patients with pre-existing liver disease.
There are no strict dietary restrictions, but consuming large amounts of caffeine or heavy meals close to bedtime may reduce the medication’s effectiveness.
Sleepose is a prescription-grade formulation with a precise 10 mg dosage, manufactured under stringent quality controls. Over-the-counter supplements vary in strength, purity, and regulatory oversight.
Because melatonin can cause residual drowsiness, individuals operating aircraft or heavy machinery should avoid use unless cleared by occupational health or aviation medical authorities.
Sleepose is a brand-name medication that contains the hormone melatonin as its sole active ingredient. It is supplied as a 10 mg oral pill and is classified as a sleeping pill in the United Kingdom. Melatonin is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and is available by prescription (POM) for specific sleep-related indications.
Melatonin is a naturally occurring hormone produced by the pineal gland in response to darkness. It helps synchronize the body’s internal clock, known as the circadian rhythm, with the external light-dark cycle. When taken as a medication, Sleepose temporarily raises circulating melatonin levels, signaling to the brain that it is nighttime. This promotes sleep onset and can improve sleep continuity. The effect typically begins within 30-60 minutes after oral ingestion, peaks at about 1-2 hours, and lasts for several hours, covering the usual night-time sleep window.
In the UK, the MHRA authorises melatonin (including Sleepose) for the short-term treatment of primary insomnia in adults aged 55 years and older. The medication is intended for a limited course-usually up to three weeks-to help establish a regular sleep pattern.
Research and clinical guidelines have explored melatonin for several conditions that are not formally approved in the UK:
Off-label use requires medical supervision and an individualized risk assessment.
Absolute contraindications
Known hypersensitivity to melatonin or any of the pill’s inactive ingredients.
Use in patients with uncontrolled severe hepatic impairment (because melatonin is metabolised in the liver).
Relative contraindications
Pregnancy or breastfeeding - safety data are limited; the medication should be avoided unless the potential benefit outweighs the risk.
Severe renal dysfunction - dose adjustment may be necessary.
Children and adolescents - melatonin is not routinely approved for routine insomnia in this age group in the UK.
Special populations
Elderly (≥55 years) - The primary approved group; start with the lowest effective dose.
Patients with epilepsy - Caution is advised; monitor for any change in seizure frequency.
Patients should provide a complete medication list-including over-the-counter products and herbal supplements-to their prescriber before starting Sleepose.
This article provides educational information about Sleepose and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
